Opioid receptors (mu-opioid receptor)
Assets acting on this target.
- Class
- Opioid antagonist
- Notes
- mechanism wave 2026-08-24 (PubMed co-occurrence, 1635 article(s)); source: https://pubmed.ncbi.nlm.nih.gov/42635925/
Related mechanisms
Opioid receptor (4)Kappa-opioid receptor (agonist, peripherally restricted) (2)Kappa-opioid receptor (inhibitor) (2)Dopamine D2 and serotonin 5-HT2A/5-HT2C receptors (antagonist); mu-opioid receptor (antagonist) (1)Dopamine D2 and serotonin 5-HT2A receptors (antagonist); mu-opioid receptor (antagonist) (1)Kappa-opioid receptor (agonist); mu-opioid receptor (antagonist) (1)
Opioid receptors (mu-opioid receptor) drugs compared
2 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Naltrexone | Not recorded | small molecule | Approved | Approved in Opioid and Alcohol Dependence |
| Oxycodone (Xtampza ER)Xtampza ER | Collegium Pharmaceutical, Inc. (BioDelivery Sciences International, acquired 2022) | small molecule | Approved | Approved in Chronic Pain |